My opinion is that the pivot is driven by non-competes [without a much needed CA style prohibition]. Long ago you needed expensive computer time or pricy tools to write software, but these days you don't need a VAX to write software or an expensive MSDN subscription provided by your employer. You can do it on your personal laptop at home with open source tools -- your employer's non-competes significantly stifle this sort of innovation. However, Biotech and life sciences needs expensive lab space, specialized plumbing and infrastructure and complex equipment -- you can't really cook up a new drug in your kitchen on the weekends as you might with some new software idea.
So I think there's still a ton of super-smart people coming out of the universities in the Boston area, but the software folks are being drawn elsewhere (Silicon Valley), whilst the biotech ones stay because of the inertia here.